These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26780497)

  • 1. Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer's disease mouse model.
    Mohamed LA; Keller JN; Kaddoumi A
    Biochim Biophys Acta; 2016 Apr; 1862(4):778-787. PubMed ID: 26780497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.
    Menet R; Bourassa P; Calon F; ElAli A
    Neurochem Int; 2020 Dec; 141():104881. PubMed ID: 33068684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
    Ding Y; Zhong Y; Baldeshwiler A; Abner EL; Bauer B; Hartz AMS
    Fluids Barriers CNS; 2021 Mar; 18(1):10. PubMed ID: 33676539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
    Vulin M; Zhong Y; Maloney BJ; Bauer B; Hartz AMS
    Fluids Barriers CNS; 2023 Oct; 20(1):70. PubMed ID: 37803468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    Zhang Y; Hu Y; Han Z; Geng Y; Xia Z; Zhou Y; Wang Z; Wang Y; Kong E; Wang X; Jia J; Zhang H
    J Alzheimers Dis; 2022; 88(1):141-154. PubMed ID: 35570485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
    Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
    Hartz AM; Miller DS; Bauer B
    Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.
    Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG
    CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
    Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
    Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
    Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
    Chai AB; Hartz AMS; Gao X; Yang A; Callaghan R; Gelissen IC
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.
    Qosa H; Abuznait AH; Hill RA; Kaddoumi A
    J Alzheimers Dis; 2012; 31(1):151-65. PubMed ID: 22504320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.
    Mohamed LA; Qosa H; Kaddoumi A
    ACS Chem Neurosci; 2015 May; 6(5):725-36. PubMed ID: 25782004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.